authID (AUID) CEO granted 800,248 stock options at $1.24 exercise price
Rhea-AI Filing Summary
authID Inc. reported that Chief Executive Officer Rhoniel Daguro received a grant of 800,248 stock options on common shares at an exercise price of $1.2400 per share. These options become exercisable starting on May 27, 2027 and expire on May 27, 2036.
According to the footnotes, 650,248 of the granted options are not exercisable unless the company’s 2026 Equity Incentive Plan is approved by stockholders, and the grant is intended to bring the CEO’s aggregate equity interest to about 6% of outstanding stock after current financing rounds. Following the transactions, Daguro holds 24,833 common shares directly and multiple existing option awards with exercise prices ranging from $3.1760 to $5.4800 per share.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 800,248 | $0.00 | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Common Stock, $0.0001 par value per share | -- | -- | -- |
Footnotes (1)
- The stock option vesting is subject to achievement of performance and service conditions, or as to the entire balance upon earlier termination on change of control. The stock option vesting is monthly over 12 months, subject to continued service to authID Inc. Of the 800,248 options granted, 650,248 options are not exercisable unless and until the Company's 2026 Equity Incentive Plan is approved by the Company's stockholders. Granted in order to bring his aggregate equity interest up to an amount equal to 6% of the Company's outstanding stock, after taking into account the shares issued and to be issued under the current financing rounds.
Key Figures
Key Terms
Stock Options financial
exercise price financial
2026 Equity Incentive Plan financial
performance and service conditions financial
change of control financial
AI-generated analysis. How Rhea-AI works. Not financial advice.